CURRENT STATE OF FINANCING INVESTMENT PROJECTS IN THE PHARMACEUTICAL SECTOR: AN ANALYTICAL STUDY
Keywords:
pharmaceutical sector, investment projects, financing mechanisms, venture capital, public–private partnershipAbstract
The pharmaceutical industry requires significant investment to sustain research, production, and innovation. This study analyzes the current state of financing investment projects in the pharmaceutical sector using statistical analysis, comparative case studies, and policy review. Results show that state financing dominates, while private and venture capital remain underdeveloped. Recommendations are made to diversify financing mechanisms and strengthen public–private partnerships.
Downloads
References
World Health Organization. (2023). Global report on effective access to medicines 2023. Geneva: WHO Press.
World Bank. (2022). Global Development Indicators: Pharmaceutical industry investments. Washington, DC.
OECD. (2021). Pharmaceutical innovation and access to medicines. OECD Publishing, Paris.
European Commission. (2022). EU Industrial R&D Investment Scoreboard 2022. Luxembourg: Publications Office of the EU.
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. https://doi.org/10.1016/j.jhealeco.2016.01.012
McKinsey & Company. (2020). Pharma’s next normal: How the sector is shaping the future. McKinsey Insights Report.
Ministry of Health of the Republic of Uzbekistan. (2023). Annual report on pharmaceutical sector development. Tashkent.
Ernst & Young. (2021). Global biotechnology report: The investment landscape in life sciences. EY Global.
PWC. (2022). Pharma 2022: Unleashing value from R&D investments. PwC Research.
Ghosh, S., & Rajan, R. (2019). Financing innovation in emerging economies: Evidence from pharmaceutical firms. Research Policy, 48(3), 719–734. https://doi.org/10.1016/j.respol.2018.11.008
